BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6196880)

  • 1. [Characteristics of neuraminidase N1 from human influenza A viruses].
    Grinbaum EB; Ivanova NA; Luzianina TIa
    Tr Inst Im Pastera; 1982; 59():20-3. PubMed ID: 6196880
    [No Abstract]   [Full Text] [Related]  

  • 2. [Determination of the antigenic specificity of the neuraminidase of influenza viruses].
    Molibog EV; Selivanov IaM; Mel'nichenko EI; Isachenko VA; Zakstel'skaia LIa
    Vopr Virusol; 1983; 28(1):46-50. PubMed ID: 6189296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antigenic specificity of the neuraminidases of epidemic strains of influenza A/H3N2 viruses circulating in the USSR 1983-1985].
    Liubovtseva OV; Iakhno MA; Zakstel'skaia LIa
    Vopr Virusol; 1987; 32(3):283-5. PubMed ID: 2445104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antigenic specificity of neuraminidase and structure of neuraminidase gene of influenza A(H1N1) serotype Hsw1N1 viruses isolated from man and animals].
    Chuvakova ZK; Dem'ianenko IV; Chaĭka OV; Shilov AA; Kim EV; Rovnova ZI; Isaeva EI; Isaeva ES
    Vopr Virusol; 1989; 34(6):656-61. PubMed ID: 2483778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antigenic relations between neuraminidases N 1 of human influenza viruses type A].
    Grinbaum EB; Ivanova NA; Luzianina TIa; Smorodintsev AA
    Virologie; 1981; 32(2):115-21. PubMed ID: 7245603
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation of immunogenic neuraminidases of human influenza viruses by a combination of genetic and biochemical procedures.
    Gallagher M; Bucher DJ; Dourmashkin R; Davis JF; Rosenn G; Kilbourne ED
    J Clin Microbiol; 1984 Jul; 20(1):89-93. PubMed ID: 6205018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of the neuraminidase specificity of influenza A and B viruses using a modified lectin test].
    Liubovtseva OV; Zakstel'skaia LIa; Ivanova VT; Oskerko TA
    Vopr Virusol; 1983; 28(6):663-8. PubMed ID: 6199899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difficulties in standardizing the neuraminidase content of influenza vaccines.
    Gérentes L; Kessler N; Aymard M
    Dev Biol Stand; 1999; 98():189-96; discussion 197. PubMed ID: 10494973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuraminidase antigenic erythrocytic diagnostic agent in determining antibodies to the neuraminidase of influenza A viruses].
    Tamendarova NCh; Shuratov IKh; Karal'nik BV; Ansarieva KG; Nietkalieva SA
    Vopr Virusol; 1985; 30(3):369-73. PubMed ID: 2413631
    [No Abstract]   [Full Text] [Related]  

  • 11. The rapid identification of human influenza neuraminidase N1 and N2 subtypes by ELISA.
    Barr IG; McCaig M; Durrant C; Shaw R
    Vaccine; 2006 Nov; 24(44-46):6675-8. PubMed ID: 16860447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complete neuraminidase of influenza A/PR8/34 (H0N1) is not detectable in its recombinant virus.
    Arora DJ; Hill-Schubert J
    Can J Microbiol; 1980 Nov; 26(11):1369-73. PubMed ID: 7214226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antigenic properties of influenza virus type A inactivated by ultraviolet irradiation].
    Bokhnevich GM; Fridman EA; Peradze TV
    Vopr Virusol; 1978; (1):74-9. PubMed ID: 77085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antigenic structure of the neuraminidases of vaccinal strains of influenza virus type A used in the production of live anti-influenza oral vaccine].
    Mel'nikova SK; Aleksandrova AN; Alekseeva AK
    Vopr Virusol; 1976; (3):287-9. PubMed ID: 62454
    [No Abstract]   [Full Text] [Related]  

  • 16. Amino acid sequence changes in antigenic variants of type A influenza virus N2 neuraminidase.
    Laver WG; Air GM; Webster RG; Markoff LJ
    Virology; 1982 Oct; 122(2):450-60. PubMed ID: 6183823
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antigen production for the influenza virus neuraminidase activity inhibition reaction].
    Popov VF; Lonskaia NI; Mel'nikova SK; Taranova GP
    Tr Inst Im Pastera; 1976; 47():56-60. PubMed ID: 1052584
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of antineuraminidase antibodies in protection against influenza].
    Aymard M; Gerentes L; Kessler N
    Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of standard conditions for the influenza virus neuraminidase inhibition test].
    Mel'nikova SK; Gracheva EN; Alekseeva AK
    Vopr Virusol; 1976; (3):283-7. PubMed ID: 988673
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998.
    Bender C; Hall H; Huang J; Klimov A; Cox N; Hay A; Gregory V; Cameron K; Lim W; Subbarao K
    Virology; 1999 Feb; 254(1):115-23. PubMed ID: 9927579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.